Tachycardia
New tachycardia study findings have been reported by D.P. Gallagher and co-researchers
Published in Cardiovascular Device Liability Week, August 24th, 2008
"Both patients were infected with the human immunodeficiency virus and were receiving treatment with ritonavir-boosted atazanavir and methadone. Discontinuation of atazanavir in both cases resulted in a reduction in the QT interval and cessation of arrhythmia," wrote D.P. Gallagher and colleagues.
The researchers concluded: "We concluded that atazanavir contributed to prolonged corrected QT interval and subsequent ventricular tachycardia."
Gallagher and colleagues published their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Abdominal Aortic Aneurysm
Study data from University of Verona update understanding of abdominal aortic aneurysm - Abiomed, Inc.
Abiomed Announces Impella 2.5 Capacity Expansion Plans in Ireland - Acorda Therapeutics
Acorda Therapeutics Presents Positive Data from Preclinical Studies of Neuregulins in Cardiac Function - Acute Ischemia
Researchers from Indiana University report details of new studies and findings in the area of acute ischemia - Acute Leukemia Therapy
Investigators at Charles University, Department of Medicine release new data on acute leukemia therapy - Acute Myeloid Leukemia
Researchers from Charles University discuss findings in acute myeloid leukemia - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
